Silence Therapeutics plc (SLN)

Silence Therapeutics Revenue

In the year 2025, Silence Therapeutics had annual revenue of $559.00K, down -98.71%. Silence Therapeutics had revenue of $34.00K in the quarter ending December 31, 2025, a decrease of -99.86%.

• Revenue (ttm): $559.00K
• Revenue Growth: -98.65%
• P/S Ratio: 484.17
• Revenue / Employee: $6,352
• Employees: 88
• Market Cap: 275.85M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	559.00K	-42.70M	-98.71%
Dec 31, 2024	43.26M	11.62M	36.71%
Dec 31, 2023	31.64M	9.99M	46.12%
Dec 31, 2022	21.66M	4.87M	29.01%
Dec 31, 2021	16.79M	9.29M	124.07%
Dec 31, 2020	7.49M	7.17M	2,215.11%
Dec 31, 2019	323.57K	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	21.62K	-928.69K	-97.72%
Dec 31, 2016	950.31K	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	23.37K	-170.40K	-87.94%
Dec 31, 2013	193.77K	-70.63K	-26.71%
Dec 31, 2012	264.40K	-812.57K	-75.45%
Dec 31, 2011	1.08M	-2.61M	-70.75%
Dec 31, 2010	3.68M	893.28K	32.03%
Dec 31, 2009	2.79M	-435.52K	-13.51%
Dec 31, 2008	3.22M	-	-